[1]岑超平,陈晓,李冲,等.维生素D与糖尿病并发症[J].国际内分泌代谢杂志,2015,(03):199-201.[doi:10.3760/cma.j.issn.1673-4157.2015.03.016]
　Cen Chaoping,Chen Xiao,Li Chong,et al.Vitamin D and diabetic complications[J].International Journal of Endocrinology and Metabolism,2015,(03):199-201.[doi:10.3760/cma.j.issn.1673-4157.2015.03.016]
点击复制

维生素D与糖尿病并发症()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
期数:
2015年03
页码:
199-201
栏目:
综述
出版日期:
2015-05-20

文章信息/Info

Title:
Vitamin D and diabetic complications
作者:
岑超平; 陈晓; 李冲; 翟绍忠
450052　郑州大学第一附属医院内分泌科
Author(s):
Cen Chaoping; Chen Xiao; Li Chong; Zhai Shaozhong.
Department of Endocrinology，The First Affiliated Hospital of Zhengzhou Medical University，Zhengzhou 450052，China
关键词:
维生素D; 糖尿病; 并发症
Keywords:
Vitamin D; Diabetes mellitus;  Complications
DOI:
10.3760/cma.j.issn.1673-4157.2015.03.016
摘要:
近年来，关于维生素D与糖尿病并发症的研究逐渐增多。其中，维生素D与糖尿病大血管病变的相关性尚有争议。而维生素D缺乏是糖尿病肾病的独立危险因素，补充维生素D能够延缓糖尿病肾病的进展。同时，多数研究提示维生素D缺乏也很可能是糖尿病视网膜病变和糖尿病周围神经病变的独立危险因素。探讨其作用机制，可能为糖尿病并发症的治疗提供新的思路。
Abstract:
In recent years，studies on vitamin D and diabetic complications are gradually increasing. The correlation between vitamin D and diabetic macroangiopathy remains controversial. However it is proved that vitamin D deficiency is the independent risk factor of diabetic nephropathy，and vitamin D supplementation can delay the progession of diabetic nephropathy. At the same time，many studies have suggested that vitamin D deficiency could be an independent risk factor of diabetic retinopathy and diabetic peripheral neuropathy. Discussion of the possible mechanism might provide new ideas for the treatment of diabetic complictations.

参考文献/References:

[1]　Menezes AR，Lamb MC，Lavie CJ，et al.Vitamin D and atherosclerosis[J].Curr Opin Cardiol，2014，29（6）：571-577. 　
[2]　Wong MS，Leisegang MS，Kruse C，et al.Vitamin D promotes vascular regeneration[J].Circulation，2014，130（12）：976-986. 　
[3]　Zittermann A.Vitamin D and cardiovascular disease[J].Anticancer Res，2014，34（9）：4641-4648. 　
[4]　Ryu OH，Chung W，Lee S，et al. The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes[J].Korean J Intern Med，2014，29（5）：620-629. 　
[5]　Alele JD，Luttrell LM，Hollis BW，et al. Relationship between vitamin D status and incidence of vascular events in the Veterans Affairs Diabetes Trial[J].Atherosclerosis，2013，228（2）：502-507. 　
[6]　Tiwari S，Pratyush DD，Gupta B，et al. Prevalence and severity of vitamin D deficiency in patients with diabetic foot infection[J].Br J Nutr，2013，109（1）：99-102. 　
[7]　López-López N，González-Curiel I，Trevi■o-Santa Cruz MB，et al. Expression and vitamin D-mediated regulation of matrix metal-loproteinases （MMPs） and tissue inhibitors of metalloproteinases （TIMPs） in healthy skin and in diabetic foot ulcers[J].Arch Dermatol Res，2014，306（9）：809-821. 　
[8]　Ignatovich IN，Kondratenko GG，Dobrovol'skaia luV.Low level of 25-OH-vitamin D as a marker of critical ischemia in case of diabetic foot syndrome[J].Khirurgiia （Mosk），2014，（3）：11-14. 　
[9]　Plum LA，Zella JB.Vitamin D compounds and diabetic nephropathy[J].Arch Biochem Biophys，2012，523（1）：87-94.
[10]　李冬梅，张颖，丁波，等.血清25羟维生素D缺乏与糖尿病肾病的关系[J].中华内科杂志，2013，52（11）：970-974.
[11]　Guan X，Yang H，Zhang W，et al.Vitamin D receptor and its protective role in diabetic nephropathy[J].Chin Med J （Engl），2014，127（2）：365-369.
[12]　Jódar-Gimeno E，Mu■oz-Torres M. Vitamin D hormone system and diabetes mellitus：lessons from selective activators of vitamin D receptor and diabetes mellitus[J].Endocrinol Nutr，2013，60（2）：87-95.
[13]　Verouti SN，Tsilibary EC，Fragopoulou E，et al.Vitamin D receptor activators upregulate and rescue podocalyxin expression in high glucose-treated human podocytes[J].Nephron Exp Nephrol，2012， 122（1-2）：36-50.
[14]　He R，Shen J，Liu F，et al.Vitamin D deficiency increases the risk of retinopathy in Chinese patients with type 2 diabetes[J].Diabet Med， 2014，31（12）：1657-1664.
[15]　Ren Z，Li W，Zhao Q，et al. The impact of 1，25-dihydroxy vitamin D3 on the expressions of vascular endothelial growth factor and transforming growth factor-β1 in the retinas of rats with diabetes[J].Diabetes Res Clin Pract，2012，98（3）： 474-480.
[16]　Albert DM，Scheef EA，Wang S，et al.Calcitriol is a potent inhibitor of retinal neovascularization[J].Invest Ophthalmol Vis Sci，2007，48（5）： 2327-2334.
[17]　Soderstrom LH，Johnson SP，Diaz VA，et al.Association between vitamin D and diabetic neuropathy in a nationally representative sample：results from 2001-2004 NHANES[J].Diabet Med， 2012， 29（1）：50-55.
[18]　Shehab D，AI-Jarallah K，Mojiminiyi OA，et al.Does Vitamin D deficiency play a role in peripheral neuropathy in type 2 diabetes?[J].Diabet Med， 2012，29（1）： 43-49.
[19]　Lee P，Chen R. Vitamin D as an analgesic for patients with type 2 diabetes and neuropathic pain[J].Arch Intern Med，2008，168（7）：771-772.
[20]　Maser RE，Lenhard MJ，Pohlig RT.Vitamin D insufficiency is associated with reduced parasympathetic nerve fiber function in type 2 diabetes[J].Endocr Pract，2015，21（2）：174-181.
[21]　Celikbilek A，Gocmen AY，Tanik N，et al.Decreased serum vitamin D levels are associated with diabetic peripheral neu-ropathy in a rural area of Turkey[J].Acta Neurol Belg，2015，115（1）：47-52.

相似文献/References:

[1]郑少雄.罗格列酮和心血管风险——近期文献解读[J].国际内分泌代谢杂志,2007,(04):231.
[2]凌厉,朱本章.胰岛素类似物安全性研究进展[J].国际内分泌代谢杂志,2007,(04):234.
[3]李颖,刘东方.餐后1小时血糖升高的意义及干预[J].国际内分泌代谢杂志,2007,(04):235.
[4]崔巍,施秉银.内质网应激介导β细胞生存/死亡的研究进展[J].国际内分泌代谢杂志,2007,(04):256.
[5]杨叶虹,胡仁明.SELDI-TOF-MS技术及其在糖尿病研究中的应用[J].国际内分泌代谢杂志,2007,(04):261.
[6]高妍.针对华人糖尿病特点优化降糖方案[J].国际内分泌代谢杂志,2007,(04):269.
[7]杨志霞,郭莹辉,杨永生,等.胰岛素泵和多次皮下注射治疗糖尿病的比较[J].国际内分泌代谢杂志,2007,(04):273.
[8]周建英,马向华.胃旁路术减肥同时改善糖代谢的机制[J].国际内分泌代谢杂志,2007,(04):285.
[9]李翠柳,朱大龙.破译肠道代谢信息,驱动治疗革新[J].国际内分泌代谢杂志,2014,(06):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
　Li Cuiliu*,Zhu Dalong..Deciphering metabolic messages from the gut drives therapeutic innovation[J].International Journal of Endocrinology and Metabolism,2014,(03):383.[doi:10.3760/cma.j.issn.1673-4157.2014.06.006]
[10]胡雅琴,包玉倩.维生素D对非酒精性脂肪性肝病的保护作用[J].国际内分泌代谢杂志,2014,(06):408.[doi:10.3760/cma.j.issn.1673-4157.2014.06.013]
　Hu Yaqin,Bao Yuqian..Protective effect of vitamin D on non-alcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2014,(03):408.[doi:10.3760/cma.j.issn.1673-4157.2014.06.013]

更新日期/Last Update: 2015-05-20